Dongfang Biotech
Beijing, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A biopharma company developing and manufacturing biologic drugs and biosimilars.
OncologyImmunology
Technology Platform
Integrated biologics development and GMP manufacturing platform for monoclonal antibodies and other therapeutic proteins.
Opportunities
Significant demand for high-quality, affordable biologics in China's expanding healthcare system.
Risk Factors
Low margins in the biosimilar sector and potential pricing pressure from national procurement policies.
Competitive Landscape
Competes in the competitive and price-driven Chinese biosimilars market against numerous domestic manufacturers.